The Business Development team focuses on increasing the economic impact of genomics research by
connecting academia and industry to bring about the
commercialization of genomics discovery.
Investing in the Future
Through its Pre-Commercialization Business Development Fund, OGI made two investments of $100,000 in proof-of-principle
companies over the last year.
The first being
ArcticDX Inc. which is developing a genetic test called
Macula Risk® to determine one's inherited risk of developing
age-related macular degene-
ration. The second investment
was in InDanio, an early-stage drug discovery and
development company with a novel screening system for
the complete human nuclear hormone receptor family.
Creating the Doorway to Genomics in Ontario
This year, a new, refreshed, improved Genomics Sector
Innovation Network – g-sin.com – was unveiled. Showcasing
Ontario's research, resources, companies,
services and Intellectual Property, g-sin.com is a
central portal to all things genomics in the province, as
well as a means through which collaborations between
researchers, industry and investors is fostered.
Showcasing Ontario on an International Stage
The Business Development team attended BIO 2010
in Chicago this past year where they showcased some
of the leading research taking place in the province.
The projects highlighted included DNA barcoding
and associated databases, the Database of Genomic
Varients, Dynemo – a software application that provides
prognoses for cancer, and CyTOF™ mass-cytometer that
is used for disease detection and characterization of
cancer cells.
Bringing Academia and Industry Together
This year, OGI ran one of its Science with Industry
Workshops. The topic of the workshop was molecular
diagnoses. Titled Dx2010 Markers to Market, the
workshop brought together leading international
researchers, regulatory representatives and entrepreneurs
from the diagnostics sector to examine regulatory
hurdles and commercialization challenges on the path
from biomarker discovery to market for molecular
diagnostics and prognostics.
Bringing the Latest Technology to the Attention
of Researchers
Over the last year, OGI ran three Technology Days, which
are designed to educate and inform Ontario researchers
about the latest and leading technology,
all of which
was developed in the province. Technology featured
included iRefWeb, the Reactome database and a training
session on bioinformatics.
